NDC 70748-274
Ganirelix Acetate 250 ug per 0.5 mL injection, solution
On the label: Lupin Pharmaceuticals, Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Lupin Limited | Nagpur, India | Makes it and packages it | Problems found, fixed voluntarilySep 16, 2025 · 1 inspection |
Recalls
- Nov 13, 2025 · Class II · Lupin Pharmaceuticals Inc.
Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.
Lots: Lot #: WB00006, Exp 12/31/2026
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Ganirelix: every company that makes it
- Form
- injection, solution, subcutaneous
- Strength
- 250 ug per 0.5 mL
- Approval
- ANDA ANDA216075
- On the market since
- Feb 14, 2024
- Package NDCs
70748-274-01- Official label
- DailyMed (National Library of Medicine), updated Oct 27, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?